Length of symptoms before referral: prognostic variable for high-grade soft tissue sarcoma?

Area of Science:

• Oncology
• Surgical Oncology
• Sarcoma Research

Background:

• The common assumption that prompt diagnosis improves outcomes for high-grade soft tissue sarcomas lacks substantial supporting data.
• This is particularly true for high-grade lesions where clinical evidence is limited.

Purpose of the Study:

• To investigate prognostic factors in high-grade soft tissue sarcoma.
• To determine if symptom duration impacts survival and disease-free survival.
• To compare diagnosis times for subcutaneous versus deep sarcomas.

Main Methods:

• Retrospective review of 381 patients with high-grade soft tissue sarcoma (1992-2007).
• Prospective data collection on time from first symptom to diagnosis.
• Analysis of survival, disease-free survival, metastasis, tumor size, and age in relation to symptom duration.

Main Results:

• Overall 5-year survival was 64.7%; disease-free survival was 54.5%.
• Tumor size and metastatic disease at diagnosis correlated with survival outcomes.
• Length of symptoms before diagnosis did not correlate with overall survival, disease-free survival, or metastasis at diagnosis.

Conclusions:

• The study data do not support the assumption that a longer symptom duration before diagnosis negatively impacts survival.
• Findings suggest that factors other than symptom duration are more critical for predicting outcomes in high-grade soft tissue sarcoma.